Status:
UNKNOWN
Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children
Lead Sponsor:
Laboratoires URGO
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
6-15 years
Phase:
PHASE4
Brief Summary
Principal focus is to evaluate the effects of omega 3 fatty acids supplementation on the ADHD children's behaviour during 12 weeks on two years. The secondary focus is to evaluate the effects of omega...
Eligibility Criteria
Inclusion
- 6 to 15 years and 11 months of age ADHD children with hyperactivity confirmed dy DSM IV criteria Children and parents' consent
Exclusion
- Without methylphenidate treatment Fish or other sea products allergic Intake of sea omega 3 fatty acids supplments more one week during 3 months before the trial Children need quickly to take methylphenidate: social, family, or school risk Intake methylphenidate 30 days before the trial or/and intake it during one consecutive week
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00770627
Start Date
October 1 2008
End Date
December 1 2010
Last Update
April 13 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Investigation Center
Bron, France, 69677
2
Hopital Cardiovasculaire Louis Pradel
Bron, France, 69677